Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease

B Remenyi, J Carapetis, R Wyber, K Taubert… - Nature Reviews …, 2013 - nature.com
In the 21st century, rheumatic fever (RF) and rheumatic heart disease (RHD) are neglected
diseases of marginalized communities. Globally, RHD remains the most-common …

Molecular epidemiology, ecology, and evolution of group A streptococci

DE Bessen, PR Smeesters, BW Beall - Microbiology spectrum, 2018 - Am Soc Microbiol
The clinico-epidemiological features of diseases caused by group A streptococci (GAS) is
presented through the lens of the ecology, population genetics, and evolution of the …

The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design

NM Van Sorge, JN Cole, K Kuipers, A Henningham… - Cell host & …, 2014 - cell.com
Summary Group A Streptococcus (GAS) is a leading cause of infection-related mortality in
humans. All GAS serotypes express the Lancefield group A carbohydrate (GAC), comprising …

Differing efficacies of lead group A streptococcal vaccine candidates and full-length M protein in cutaneous and invasive disease models

T Rivera-Hernandez, M Pandey, A Henningham… - MBio, 2016 - Am Soc Microbiol
ABSTRACT Group A Streptococcus (GAS) is an important human pathogen responsible for
both superficial infections and invasive diseases. Autoimmune sequelae may occur upon …

A synthetic M protein peptide synergizes with a CXC chemokine protease to induce vaccine-mediated protection against virulent streptococcal pyoderma and …

M Pandey, E Langshaw, J Hartas, A Lam… - The Journal of …, 2015 - journals.aai.org
Infections caused by Streptococcus pyogenes (group A Streptococcus [GAS]) are highly
prevalent in the tropics, in developing countries, and in the Indigenous populations of …

Self-assembly of trimethyl chitosan and poly (anionic amino acid)-peptide antigen conjugate to produce a potent self-adjuvanting nanovaccine delivery system

RJ Nevagi, W Dai, ZG Khalil, WM Hussein… - Bioorganic & Medicinal …, 2019 - Elsevier
Short peptides derived from virulent pathogen proteins are promising antigens for the
development of vaccines against infectious diseases. However, in order to mimic the danger …

Combinatorial synthetic peptide vaccine strategy protects against hypervirulent CovR/S mutant streptococci

M Pandey, R Mortensen, A Calcutt, J Powell… - The Journal of …, 2016 - journals.aai.org
Cluster of virulence responder/sensor (CovR/S) mutant group A streptococci (GAS) are
serious human pathogens of multiple M protein strains that upregulate expression of …

Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity

M Zaman, S Chandrudu, AK Giddam, J Reiman… - …, 2014 - Taylor & Francis
Aim: Utilize lipopeptide vaccine delivery system to develop a vaccine candidate against
Group A Streptococcus. Materials & methods: Lipopeptides synthesized by solid-phase …

Health system and patient-level factors serving as facilitators and barriers to rheumatic heart disease care in Sudan

JG Edwards, M Barry, D Essam, M Elsayed… - Global Health Research …, 2021 - Springer
Background Rheumatic heart disease (RHD) remains a leading cause of morbidity and
mortality in Sub-Saharan Africa despite widely available preventive therapies such as …

Epidemiology of infective endocarditis: novel aspects in the twenty-first century

V Arshad, KM Talha, LM Baddour - Expert Review of …, 2022 - Taylor & Francis
Introduction The epidemiology of infective endocarditis (IE) in this millennium has changed
with emergence of new risk factors and reemergence of others. This, coupled with …